FDA 批准Neffy, 一个无针肾上腺素鼻涕喷剂 给有严重过敏症的儿童。 FDA approves Neffy, a needle-free epinephrine nasal spray for kids with severe allergies.

林业发展局批准了无针肾上腺素鼻涕喷剂Neffy,用于治疗体重为15-30公斤的4岁及4岁以上儿童的严重过敏反应。 The FDA has approved Neffy, a needle-free epinephrine nasal spray, for treating severe allergic reactions in children aged 4 years and older weighing 15-30kg. 与传统注射器相比,这种新的治疗旨在改进使用机会和方便程度,有可能降低与针头产品有关的风险。 This new treatment aims to improve access and ease of use compared to traditional injectors, potentially reducing the risk associated with needle-based products. 预计到2025年5月,美国商店将可提供Neffy。 Neffy is expected to be available in U.S. stores by May 2025.